134 related articles for article (PubMed ID: 24294471)
1. The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer.
Shafaei S; Sharbatdaran M; Kamrani G; Khafri S
Caspian J Intern Med; 2013; 4(4):768-72. PubMed ID: 24294471
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CD166 and HER-2 in different types of gastric cancer.
Moradi L; Tajik F; Saeednejad Zanjani L; Panahi M; Gheytanchi E; Biabanaki ZS; Kazemi-Sefat GE; Hashemi F; Dehghan Manshadi M; Madjd Z
Clin Transl Oncol; 2024 Mar; 26(3):664-681. PubMed ID: 37537510
[TBL] [Abstract][Full Text] [Related]
3. Hotspot
Wong HL; Ng LPW; Koh SP; Chan LWC; Wong EYK; Xue VW; Tsang HFA; Chan AKC; Chiu KY; Cheuk W; Wong SCC
Oncotarget; 2018 Apr; 9(29):20426-20438. PubMed ID: 29755662
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
5. CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma.
Mărgaritescu C; Pirici D; Cherciu I; Bărbălan A; Cârtână T; Săftoiu A
J Gastrointestin Liver Dis; 2014 Jun; 23(2):161-70. PubMed ID: 24949608
[TBL] [Abstract][Full Text] [Related]
6. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.
Ni C; Zhang Z; Zhu X; Liu Y; Qu D; Wu P; Huang J; Xu AX
PLoS One; 2013; 8(8):e70958. PubMed ID: 23940674
[TBL] [Abstract][Full Text] [Related]
8. CD166 expression in dentigerous cyst, keratocystic odontogenic tumor and ameloblastoma.
Andisheh-Tadbir A; Gorgizadeh A
J Clin Exp Dent; 2016 Jul; 8(3):e236-40. PubMed ID: 27398171
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis.
Han S; Yang W; Zong S; Li H; Liu S; Li W; Shi Q; Hou F
Oncotarget; 2017 Sep; 8(38):64373-64384. PubMed ID: 28969077
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.
Langan RC; Mullinax JE; Ray S; Raiji MT; Schaub N; Xin HW; Koizumi T; Steinberg SM; Anderson A; Wiegand G; Butcher D; Anver M; Bilchik AJ; Stojadinovic A; Rudloff U; Avital I
J Cancer; 2012; 3():231-40. PubMed ID: 22670157
[TBL] [Abstract][Full Text] [Related]
13. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
[TBL] [Abstract][Full Text] [Related]
14. Indium-111-labeled CD166-targeted peptide as a potential nuclear imaging agent for detecting colorectal cancer stem-like cells in a xenograft mouse model.
Guan SS; Wu CT; Liao TZ; Luo TY; Lin KL; Liu SH
EJNMMI Res; 2020 Feb; 10(1):13. PubMed ID: 32096011
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features.
Ghavam-Nasiri MR; Rezaei E; Ghafarzadegan K; Seilanian-Toosi M; Malekifard H
Arch Iran Med; 2007 Jan; 10(1):38-42. PubMed ID: 17198452
[TBL] [Abstract][Full Text] [Related]
17. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
19. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
20. Investigation of CCR7 Marker Expression Using Immunohistochemical Method and Its Association with Clinicopathologic Properties in Patients with Breast Cancer.
Vahedi L; Ghasemi M; Yazdani J; Ranjbar S; Nouri B; Alizadeh A; Afshar P
Int J Hematol Oncol Stem Cell Res; 2018 Apr; 12(2):103-110. PubMed ID: 30233771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
